Hims & Hers Health, Inc.HIMSEarnings & Financial Report
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
Revenue
$278.2M
Gross Profit
$229.1M
Operating Profit
$9.9M
Net Profit
$11.1M
Gross Margin
82.4%
Operating Margin
3.6%
Net Margin
4.0%
YoY Growth
45.8%
EPS
$0.05
Financial Flow
Hims & Hers Health, Inc. Q1 2024 Financial Summary
Hims & Hers Health, Inc. reported revenue of $278.2M (up 45.8% YoY) for Q1 2024, with a net profit of $11.1M (up 210.5% YoY) (4.0% margin). Cost of goods sold was $49.1M, operating expenses totaled $219.2M.
Key Financial Metrics
| Total Revenue | $278.2M |
|---|---|
| Net Profit | $11.1M |
| Gross Margin | 82.4% |
| Operating Margin | 3.6% |
| Report Period | Q1 2024 |
Revenue Breakdown
Hims & Hers Health, Inc. Q1 2024 revenue of $278.2M breaks down across 2 segments, led by Sales Channel Directly To Consumer at $267.8M (96.3% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Sales Channel Directly To Consumer | $267.8M | 96.3% |
| Sales Channel Through Intermediary | $10.4M | 3.7% |
Hims & Hers Health, Inc. Revenue by Segment — Quarterly Trend
Hims & Hers Health, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Sales Channel Directly To Consumer and Sales Channel Through Intermediary) has evolved quarter over quarter.
| Segment | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Sales Channel Directly To Consumer | — | $589.1M | $536.9M | $576.4M |
| Sales Channel Through Intermediary | — | $9.9M | $8.0M | $9.6M |
Hims & Hers Health, Inc. Annual Revenue by Year
Hims & Hers Health, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $2.3B).
| Year | Annual Revenue |
|---|---|
| 2025 | $2.3B |
| 2024 | $1.5B |
| 2023 | $872.0M |
| 2022 | $526.9M |
Hims & Hers Health, Inc. Quarterly Revenue & Net Profit History
Hims & Hers Health, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $617.8M | +28.4% | $20.6M | 3.3% |
| Q3 2025 | $599.0M | +49.2% | $15.8M | 2.6% |
| Q2 2025 | $544.8M | +72.6% | $42.5M | 7.8% |
| Q1 2025 | $586.0M | +110.7% | $49.5M | 8.4% |
| Q4 2024 | $481.1M | +95.1% | $26.0M | 5.4% |
| Q3 2024 | $401.6M | +77.1% | $75.6M | 18.8% |
| Q2 2024 | $315.6M | +51.8% | $13.3M | 4.2% |
| Q1 2024 | $278.2M | +45.8% | $11.1M | 4.0% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $278.2M | $315.6M | $401.6M | $481.1M | $586.0M | $544.8M | $599.0M | $617.8M |
| YoY Growth | 45.8% | 51.8% | 77.1% | 95.1% | 110.7% | 72.6% | 49.2% | 28.4% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $448.1M | $480.5M | $602.3M | $707.5M | $891.7M | $1.88B | $2.23B | $2.15B |
| Liabilities | $103.6M | $118.5M | $162.2M | $230.8M | $342.4M | $1.31B | $1.65B | $1.61B |
| Equity | $344.5M | $362.0M | $440.1M | $476.7M | $549.3M | $562.7M | $581.0M | $540.9M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $25.8M | $53.6M | $85.3M | $86.4M | $109.1M | $-19.1M | $148.7M | $61.3M |